Journal of Addiction Research & Therapy
Open Access
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 4859
Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report
Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- SafetyLit
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Journal of Addiction Research & Therapy : Citations & Metrics Report
Articles published in Journal of Addiction Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Addiction Research & Therapy has got h-index 34, which means every article in Journal of Addiction Research & Therapy has got 34 average citations.
Following are the list of articles that have cited the articles published in Journal of Addiction Research & Therapy.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Year wise published articles |
119 | 61 | 59 | 24 | 28 | 24 | 59 | 48 |
Year wise citations received |
168 | 573 | 612 | 590 | 545 | 567 | 473 | 440 |
| Journal total citations count | 4859 |
| Journal impact factor | 9.79 |
| Journal 5 years impact factor | 14.65 |
| Journal cite score | 13.41 |
| Journal h-index | 34 |
| Journal h-index since 2018 | 26 |
 |
Twining RC, Tuscher JJ, Doncheck EM, Frick KM, Mueller D. Proof Only. Learning & Memory.;120(20):1-8. |
| View at Publisher | View at Google Scholar | |
|
Becker JB (2016) Sex differences in addiction. Dialogues in clinical neuroscience 18: 395. |
| View at Publisher | View at Google Scholar | |
|
Becker JB, McClellan ML, Reed BG (2017) Sex differences, gender and addiction. Journal of neuroscience research 2: 136-147. |
| View at Publisher | View at Google Scholar | |
|
Richard JE, Anderberg RH, López-Ferreras L, Olandersson K, Skibicka KP (2016) Sex and estrogens alter the action of glucagon-like peptide-1 on reward. Biology of sex differences 7: 6. |
| View at Publisher | View at Google Scholar | |
|
Twining RC, Tuscher JJ, Doncheck EM, Frick KM, Mueller D (2013) 17β-Estradiol is necessary for extinction of cocaine seeking in female rats. Learning & memory 20: 300-306. |
| View at Publisher | View at Google Scholar | |
|
Cruz G, Riquelme R, Espinosa P, Jara P, Dagnino-Subiabre A, Renard GM, Sotomayor-Zarate R (2014) Neonatal exposure to estradiol valerate increases dopamine content in nigrostriatal pathway during adulthood in the rat. Hormone and Metabolic Research 46: 322-327. |
| View at Publisher | View at Google Scholar | |
|
Cox KH, Bonthuis PJ, Rissman EF (2014) Mouse model systems to study sex chromosome genes and behavior: relevance to humans. Frontiers in neuroendocrinology 35: 405-419. |
| View at Publisher | View at Google Scholar | |
|
Perry AN, Westenbroek C, Becker JB (2013) The development of a preference for cocaine over food identifies individual rats with addiction-like behaviors. PloS one 8: e79465. |
| View at Publisher | View at Google Scholar | |
|
dos Reis AS, em Álcool UD. Revisão da Literatura Sobre a Associação entre Tabagismo e Esquizofrenia. |
| View at Publisher | View at Google Scholar | |
|
Almadana Pacheco V. Niveles de ansiedad y depresión en los fumadores que acuden a una consulta de deshabituación tabáquica y factores relacionados. |
| View at Publisher | View at Google Scholar | |
|
García-Portilla MP, Bobes J (2016) Programas de cesación tabáquica para personas con esquizofrenia: una necesidad urgente no cubierta. Revista de Psiquiatría y Salud Mental 9: 181-184. |
| View at Publisher | View at Google Scholar | |
|
Roig Cutillas P, Pinet Ogué M, Ballbè Gibernau M, Nieva Rifá G, Mondon Vehils S, et al. Vareniclina en el tratamiento del tabaquismo: efi cacia y seguridad en población general, psiquiátrica y drogodependiente. |
| View at Publisher | View at Google Scholar | |
|
Kurita M, García-Bea A, González-Maeso J (2016) Novel Targets for Drug Treatment in Psychiatry. InThe Medical Basis of Psychiatry. Springer New York. |
| View at Publisher | View at Google Scholar | |
|
García-Portilla MP, Bobes J (2016) Smoking cessation programs for persons with schizophrenia: An urgent unmet need. Revista de psiquiatria y salud mental 9: 181. |
| View at Publisher | View at Google Scholar | |
|
Deepika M. Research and Reviews: Journal of Medical and Health Sciences. |
| View at Publisher | View at Google Scholar | |
|
Garcia-Portilla MP, Garcia-Alvarez L, Sarramea F, Galvan G, Diaz-Mesa E, et al. (2016) It is feasible and effective to help patients with severe mental disorders to quit smoking: An ecological pragmatic clinical trial with transdermal nicotine patches and varenicline. Schizophrenia research 176: 272-280. |
| View at Publisher | View at Google Scholar | |
|
Hughes JR (2016) Varenicline as a cause of suicidal outcomes. Nicotine & Tobacco Research 18: 2-9. |
| View at Publisher | View at Google Scholar | |
|
Roberts E, Eden Evins A, McNeill A, Robson D (2016) Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network metaâanalysis. Addiction. |
| View at Publisher | View at Google Scholar | |
|
Kishi T, Iwata N (2015) Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis. European archives of psychiatry and clinical neuroscience 265: 259-268. |
| View at Publisher | View at Google Scholar | |
|
Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, et al. (2016) Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. The Lancet 387: 2507-2520. |
| View at Publisher | View at Google Scholar | |
